We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
First Merchants
FRME
$2.68B
| $1.98M | ﹤0.01% |
50,308
+1,159
| +2% | +$45.2K |
|
1552
Hyatt Hotels
H
$16.4B
| $1.98M | ﹤0.01% |
36,646
+3,316
| +10% | +$179K |
|
1553
Super Micro Computer
SMCI
$18.4B
| $1.98M | ﹤0.01% |
780,090
+217,020
| +39% | +$575K |
|
1554
Cavco Industries
CVCO
$4.22B
| $1.98M | ﹤0.01% |
16,988
+4,636
| +38% | +$503K |
|
1555
WisdomTree
WT
$2.96B
| $1.98M | ﹤0.01% |
217,762
+2,746
| +1% | +$26.6K |
|
1556
Banc of California
BANC
$3.03B
| $1.98M | ﹤0.01% |
95,414
+27,539
| +41% | +$512K |
|
|
BGG
1557
DELISTED
Briggs & Stratton Corp.
BGG
| $1.97M | ﹤0.01% |
87,937
+21,442
| +32% | +$466K |
|
|
GCI
1558
DELISTED
Gannett Co., Inc
GCI
| $1.97M | ﹤0.01% |
235,357
+62,490
| +36% | +$558K |
|
1559
HubSpot
HUBS
$12.2B
| $1.97M | ﹤0.01% |
32,534
+973
| +3% | +$55.1K |
|
|
VGR
1560
DELISTED
Vector Group Ltd.
VGR
| $1.97M | ﹤0.01% |
154,574
+5,621
| +4% | +$75.6K |
|
1561
Emergent Biosolutions
EBS
$373M
| $1.97M | ﹤0.01% |
67,742
+19,253
| +40% | +$586K |
|
1562
Boise Cascade
BCC
$2.69B
| $1.96M | ﹤0.01% |
73,402
+21,499
| +41% | +$559K |
|
|
MNDT
1563
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $1.96M | ﹤0.01% |
155,416
+12,522
| +9% | +$149K |
|
|
DO
1564
DELISTED
Diamond Offshore Drilling
DO
| $1.95M | ﹤0.01% |
116,940
+5,411
| +5% | +$91.9K |
|
1565
GoDaddy
GDDY
$11B
| $1.95M | ﹤0.01% |
51,335
+1,510
| +3% | +$54.7K |
|
1566
Insteel Industries
IIIN
$593M
| $1.95M | ﹤0.01% |
53,859
+12,376
| +30% | +$446K |
|
1567
Rexford Industrial Realty
REXR
$8.42B
| $1.94M | ﹤0.01% |
86,308
+5,809
| +7% | +$133K |
|
1568
SPS Commerce
SPSC
$2.64B
| $1.94M | ﹤0.01% |
66,422
+19,260
| +41% | +$592K |
|
|
TVTY
1569
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $1.94M | ﹤0.01% |
66,768
+18,426
| +38% | +$486K |
|
|
CFNL
1570
DELISTED
Cardinal Financial Corp
CFNL
| $1.94M | ﹤0.01% |
64,912
-900
| -1% | -$27.8K |
|
|
ACOR
1571
DELISTED
Acorda Therapeutics
ACOR
| $1.94M | ﹤0.01% |
770
+218
| +39% | +$627K |
|
|
PRAH
1572
DELISTED
PRA Health Sciences, Inc.
PRAH
| $1.94M | ﹤0.01% |
29,736
+1,346
| +5% | +$79.3K |
|
1573
WesBanco
WSBC
$3.97B
| $1.92M | ﹤0.01% |
50,459
+2,031
| +4% | +$82.1K |
|
|
HF
1574
DELISTED
HFF Inc.
HF
| $1.92M | ﹤0.01% |
69,351
+19,230
| +38% | +$564K |
|
|
KG
1575
Kestrel Group
KG
$69.4M
| $1.92M | ﹤0.01% |
6,841
+2,175
| +47% | +$716K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.